Anna Moore

An advocate for integrating knowledge on cancer imaging and therapy, Dr. Anna Moore serves as the Director of the Precision Health Program at Michigan State University. With over 27 years of experience in the fields of chemistry, bioorganic chemistry, and cancer imaging, Dr. Moore has established herself as a leading figure in the scientific community. Her work primarily focuses on the discovery of novel targets for the eradication of cancer and the development of theranostic agents, which are pivotal in both imaging and treating cancer and diabetes. Dr. Moore holds esteemed professorships in both Radiology and Physiology, where she contributes significantly to the academic and research environment. Her innovative research has led to groundbreaking advancements in cancer therapy, particularly in the integration of diagnostic and therapeutic processes. This dual approach not only enhances the precision of cancer treatment but also improves patient outcomes, aligning with her commitment to advancing healthcare solutions. In addition to her research endeavors, Dr. Moore is actively involved in several international scientific societies, where she collaborates with fellow researchers to push the boundaries of current scientific understanding. Her contributions to the field have been recognized through numerous awards, highlighting her dedication to both research and teaching. Dr. Moore's passion for education is evident in her mentorship of students and young researchers, fostering the next generation of scientists. Her teaching philosophy emphasizes the importance of interdisciplinary collaboration and innovation, encouraging students to explore the intersections of various scientific disciplines. Through her leadership at Michigan State University, Dr. Moore continues to drive forward the Precision Health Program, aiming to tailor healthcare solutions to individual needs. Her work not only advances scientific knowledge but also has a profound impact on improving patient care and treatment strategies.